Financial statements Instytut Biotechnologii Surowic I Szczepionek Biomed - Skrót Firmy Ibss Biomed S.a.
Cash flow statement of Instytut Biotechnologii Surowic I Szczepionek Biomed - Skrót Firmy Ibss Biomed S.a.
Company age:
Age:
23 y. 7 m. 26 d.
Share capital:
Share capital:
4 200 000 PLN
Cash inflows of INSTYTUT BIOTECHNOLOGII SUROWIC I SZCZEPIONEK BIOMED - SKRÓT FIRMY IBSS BIOMED S.A.
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Net cash from operating expenses | 23 545 300,78 | 22 860 119,86 | 17 955 593,52 | 2 886 988,25 | 14 978 028,82 | 45 447 850,31 |
| Net cash flow from investing activities | -12 706 387,80 | -6 979 171,53 | -46 720 637,14 | 3 244 939,06 | -11 219 843,06 | -37 141 065,35 |
| Net cash flow from financial activities | -879 715,47 | -452 217,13 | 1 453 578,27 | -15 000,00 | 189 580,01 | 371 714,50 |
| Total net cash flow | 9 959 197,51 | 15 428 731,20 | -27 311 465,35 | 6 116 927,31 | 3 947 765,77 | 8 678 499,46 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.